← Back to Clinical Trials
Recruiting NCT07415967

NCT07415967 The Effect of a Dual-Task Technique-Based Exercise Program on Clinical Outcomes in Rotator Cuff Related Shoulder Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07415967
Status Recruiting
Phase
Sponsor Istanbul University
Condition Rotator Cuff Related Shoulder Pain
Study Type INTERVENTIONAL
Enrollment 46 participants
Start Date 2026-02-16
Primary Completion 2027-02-16

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Patient EducationDual-Task-Based Exercise TherapyStandard Exercise Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 46 participants in total. It began in 2026-02-16 with a primary completion date of 2027-02-16.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this clinical trial is to investigate the effects of a dual-task-based exercise program on clinical outcomes in individuals with rotator cuff-related shoulder pain. The study will evaluate the effects of a dual-task exercise approach, in which physical exercises are performed concurrently with cognitive tasks, on pain, functional status, pain catastrophizing and kinesiophobia. These results will be compared with those of a standard shoulder rehabilitation program. The main questions this study aims to answer are: * Is there a difference in pain levels between individuals with rotator cuff-related shoulder pain who participate in a dual-task-based exercise program and those who participate in a standard exercise program? * Is there a difference between these two exercise approaches in terms of shoulder function and psychosocial factors? Participants will: * Participate in either a dual-task-based shoulder exercise program or a standard shoulder exercise program twice per week for 6 weeks. * Undergo clinical assessments at baseline, at week 6, and at week 12.

Eligibility Criteria

Inclusion Criteria: * Aged between 18 and 65 years * Diagnosis of impingement syndrome, subacromial bursitis, rotator cuff tendinopathy, or partial rotator cuff tear * Shoulder pain level ≥3 according to the Numeric Pain Rating Scale (NPRS) * Shoulder pain persisting for at least 3 months Exclusion Criteria: * Diagnosis of shoulder instability, adhesive capsulitis, or full-thickness or massive rotator cuff tear * Presence of musculoskeletal, neurological, and/or psychological conditions that would prevent participation in an exercise program * History of shoulder surgery * Having received physiotherapy or corticosteroid injection treatment for shoulder pain within the past 6 months * Presence of cognitive impairment that would prevent participation in dual-task exercise activities

Contact & Investigator

Central Contact

İrem Ece İçöz, Bachelor's degree

✉ iremece.icoz@ogr.iuc.edu.tr

📞 90+ 5511040686

Frequently Asked Questions

Who can join the NCT07415967 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Rotator Cuff Related Shoulder Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07415967 currently recruiting?

Yes, NCT07415967 is actively recruiting participants. Contact the research team at iremece.icoz@ogr.iuc.edu.tr for enrollment information.

Where is the NCT07415967 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07415967 clinical trial?

NCT07415967 is sponsored by Istanbul University. The trial plans to enroll 46 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology